Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05560932 · ClinicalTrials.gov registry record · NA
HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 1
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT05560932: Completed NA study, sponsored by Yale University.
NCT05560932 is a NA study that has completed, run by Yale University. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05560932, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This pilot intervention will consist of a brief intervention for patients with HIV who take 5 or more medications and currently (within the past month) consume alcohol. The focus of this pilot will be on bothersome symptoms and the impact of alcohol use and medications on these symptoms. The rationale is that any alcohol use may interact with medications in serious ways leading to adverse outcomes, including bothersome symptoms.
Primary Outcome
Number of participants that enrolled and provided informed consent
Interventions
- BEHAVIORAL IMB-motivational interviewing (MI) techniques (IMB-MI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-03-06 |
| Est. Completion | 2024-01-04 |
| Phase | NA |
What the finished NCT05560932 record still lists
NCT05560932 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which IMB-motivational interviewing (MI) techniques (IMB-MI) is the first listed.
NCT05560932 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05560932 about?
NCT05560932 is a clinical study titled "HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 1". This pilot intervention will consist of a brief intervention for patients with HIV who take 5 or more medications and currently (within the past month) consume alcohol. The focus of this pilot will be on bothersome symptoms and the impact of alcohol use and medications on these symptoms. The rationa...
What is the current status of trial NCT05560932?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2023-03-06. Estimated completion is 2024-01-04.
What interventions are being tested in trial NCT05560932?
The interventions under investigation include: IMB-motivational interviewing (MI) techniques (IMB-MI) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05560932?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05560932's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI